These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 5935446
1. Comparison of the BCG vaccine produced in Poland and BCG vaccines produced from BCG substrains of various origin. Buraczewska M, Kurylowicz W, Paklerska-Pobratyn H. Pol Med J; 1966; 5(1):95-102. PubMed ID: 5935446 [No Abstract] [Full Text] [Related]
3. [COMPARISON OF BCG VACCINES PRODUCED IN POLAND WITH BCG VACCINES PREPARED FROM BCG SUBSTRAINS OF VARIOUS ORIGINS]. BURACZEWSKA M, KURYLOWICZ W, PAKLERSKA-POBRATYN H. Gruzlica (1926); 1964 Sep; 32():781-8. PubMed ID: 14249995 [No Abstract] [Full Text] [Related]
5. [Comparison of biological properties of BCG vaccines used in Poland 1964-1968]. Buraczewska M, Paklerska-Pobratyn H, Pichula K. Gruzlica; 1969 Oct; 37(10):901-6. PubMed ID: 5366981 [No Abstract] [Full Text] [Related]
6. [Comparative study of BCG vaccines: Polish, Danish and Japanese -- laboratory tests]. Janaszek W. Przegl Epidemiol; 1994 Oct; 48(3):285-92. PubMed ID: 7938633 [Abstract] [Full Text] [Related]
9. [Examination of protein MPB 70 properties in BCG substrains used for the production of Polish antituberculosis vaccines]. Janaszek W, Wysokińska T, Aleksandrowicz J. Med Dosw Mikrobiol; 1998 Oct; 50(1-2):47-54. PubMed ID: 9857613 [Abstract] [Full Text] [Related]
14. [Experimental study on BCG vaccination in respiratory tract, with special reference to a comparison with other vaccination methods. 1. Emphasis on the fate of BCG vaccine in vaccinated animals]. Miyajima H. Nihon Shonika Gakkai Zasshi; 1965 Jul; 69(7):627-31. PubMed ID: 5894385 [No Abstract] [Full Text] [Related]
15. Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test". Buraczewska M, Chodkowska S, Paklerska-Pobratyn H. Pol Med J; 1969 Jul; 8(5):1136-42. PubMed ID: 4245977 [No Abstract] [Full Text] [Related]
16. [Variability of the BCG Moreau substrain. II. Comparison of the allergizing and protective properties of BCG substrains of various origins]. Janaszek W. Med Dosw Mikrobiol; 1983 Jul; 35(2):97-105. PubMed ID: 6369043 [No Abstract] [Full Text] [Related]
17. [Comparative studies of 5 BCG substrains. IV. Development of hemagglutinating antibodies in rabbits vaccinated with BCG vaccines of different origins]. Gheorghiu M, Paraschivesco M. Arch Roum Pathol Exp Microbiol; 1969 Jul; 28(2):549-55. PubMed ID: 5400046 [No Abstract] [Full Text] [Related]
18. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A. Sugawara I, Udagawa T, Taniyama T. Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096 [Abstract] [Full Text] [Related]
19. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium. de Lisle GW, Wards BJ, Buddle BM, Collins DM. Tuberculosis (Edinb); 2005 Mar; 85(1-2):73-9. PubMed ID: 15687030 [Abstract] [Full Text] [Related]
20. [Comparison of the Brazilian, Russian and French BCG substrains based on the "safety test"]. Buraczewska M, Chodkowska S, Paklerska-Pobratyn H. Gruzlica; 1969 Feb; 37(2):93-9. PubMed ID: 4891544 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]